Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 101 to 150 of 201 results for dementia

  1. Lumbar infusion test for the investigation of normal pressure hydrocephalus (HTG169)

    Evidence-based recommendations on the lumbar infusion test for the investigation of normal pressure hydrocephalus. This involves inserting a lumbar needle into the spinal sac, recording the pressure of the CSF as fluid is infused into the sac.

  2. History of NICE

    the Quality Outcomes Framework (QOF). 2010 First quality standard QS1 Dementia: support in health and social care (March). Read more...

  3. Depression in adults (QS8)

    This quality standard covers the clinical assessment and management of depression in adults aged 18 and over. It describes high-quality care in priority areas for improvement.

  4. Care and support planning:- What are the most effective methods of care planning for people who do not have regular contact with an informal carer?

    details Comes from guidance Dementia: assessment, management and support for people living with dementia and their carers...

  5. YOURmeds for medication support in long-term conditions (MIB289)

    NICE has developed a medtech innovation briefing (MIB) on YOURmeds for medication support in long-term conditions .

  6. Delirium in long-term care: How common is delirium and what are its adverse outcomes in people in long-term care?

    whether people in long-term care, who already have a high risk of death, dementia and other adverse outcomes, have a further increased...

  7. Physical activity: for NHS staff, patients and carers (QS84)

    This quality standard covers encouraging physical activity in people of all ages who are in contact with the NHS, including staff, patients and carers. It describes high-quality care in priority areas for improvement.

  8. New pharmaceutical treatments for non-Alzheimer dementias [ID380]

    Discontinued Reference number: GID-TAG369

  9. Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges (NG11)

    This guideline covers interventions and support for children, young people and adults with a learning disability and behaviour that challenges. It highlights the importance of understanding the cause of behaviour that challenges, and performing thorough assessments so that steps can be taken to help people change their behaviour and improve their quality of life. The guideline also covers support and intervention for family members or carers.

  10. Develop case identification tools for common mental health problems:- Develop or adapt reliable and valid tools for the case identification of common mental health problems in people with learning disabilities, for routine use in primary care, social care and education settings.

    common mental health problems such as depression and anxiety disorders, or dementia in Down's syndrome. As a result, the identification...

  11. Aducanumab for treating mild cognitive impairment and mild dementia caused by Alzheimer's disease [ID3763]

    Discontinued Reference number: GID-TA10739

  12. What is the clinical and cost effectiveness of treatment (antithyroid drugs or radioactive iodine) for improving long-term health outcomes for people with subclinical hyperthyroidism?

    associated with an increased risk of atrial fibrillation, osteoporosis, dementia, and death, including death from cardiovascular...

  13. Cardiovascular disease. Patient decision aid on should I take a statin?

    whether statins might cause dementia. There is no good evidence that statins do this (but some people who take statins will get...

  14. Insertion of a magnetic bead band for faecal incontinence (HTG336)

    Evidence-based recommendations on insertion of a magnetic-bead band for faecal incontinence. This involves placing a ring of magnetic beads into a tunnel made around the anus to prevent incontinence.

  15. Health Technology Assessment Innovation Laboratory (HTA Lab)

    NICE's HTA Lab enables us to develop creative solutions to complex problems in health technology assessment.

  16. Thyroid disease: assessment and management (NG145)

    This guideline covers investigating all suspected thyroid disease and managing primary thyroid disease (related to the thyroid rather than the pituitary gland). It does not cover managing thyroid cancer or thyroid disease in pregnancy. It aims to improve quality of life by making recommendations on diagnosis, treatment, long-term care and support.

  17. Urinary incontinence and pelvic organ prolapse in women: management (NG123)

    This guideline covers assessing and managing urinary incontinence and pelvic organ prolapse in women aged 18 and over. It also covers complications associated with mesh surgery for these conditions.

  18. Psychotic symptoms (hallucinations and delusions):- What is the effectiveness of rivastigmine compared with atypical antipsychotic drugs for treating psychotic symptoms (particularly hallucinations and delusions) associated with Parkinson's disease?

    some effectiveness in improving behavioural symptoms in people with Parkinson's disease dementia. At present, no evidence exists to...

  19. What is the effectiveness of statin therapy in older people?

    statins in preventing or promoting other chronic diseases of ageing such as dementia, Parkinson's disease, or age-related macular...

  20. Daily mouth care for residents:- Does the delivery of a daily mouth care regimen in care homes maintain or improve adult residents' oral health-related quality of life?

    adults with poor physical health, or a short life expectancy, or adults with dementia. It is important to understand the impact of oral...

  21. Does early review of service provision and referral to additional specialist palliative care services improve outcomes for adults with progressive non-cancer disease thought to be approaching the end of their life?

    with life-limiting neurological disease, such as motor neurone disease or dementia. Such patients are typically referred very late to...

  22. Cognitive assessment:- What is the impact of assessing for cognitive and behaviour change in people with motor neurone disease (MND) on clinical practice, the person and their family and carers? Does repeated assessment provide more benefit than assessment at a single point at diagnosis?

    studies demonstrate that up to 15% of people with MND have frontotemporal dementia. A further third of people with MND have changes in...

  23. Effectiveness and costs of oral health interventions for care home residents:- How effective and cost effective are oral health interventions in care homes including suitableperson-centred outcome measures?

    differential effects on sub-populations in care homes. This includes: people with dementia, people in poor physical health, those with a...

  24. Environmental adaptations aimed at reducing the risk of falling in older inpatients:- What environmental adaptations can be made in existing inpatient units, and should be considered when inpatient units are built, to reduce the risk of falls and injuries in older inpatients?

    Any explanatory notes(if applicable) Why this is important:- Dementia, delirium, poor mobility and balance, urgent or frequent toilet...

  25. Interventions for preventing falls in older inpatients:- How can falls among older inpatients be prevented? Which patients are most likely to benefit from falls prevention interventions, and does the effectiveness of interventions relate to the patient's length of stay?

    nor has their effectiveness in specific subgroups such as patients with dementia. High-quality randomised controlled trials conducted in...

  26. Renal and ureteric stones (QS195)

    This quality standard covers assessing and managing renal and ureteric stones in children, young people and adults. It describes high-quality care in priority areas for improvement.

  27. Telecare:- What types of telecare are most effective and cost effective, when provided to older people as part of a package of home care?

    acceptability and accessibility (particularly for people with complex needs such as dementia). Cost information from a societal...

  28. Premature ovarian insufficiency:- What are the main clinical manifestations of premature ovarian insufficiency and the short- and long-term impact of the most common therapeutic interventions?

    an increased risk of osteoporosis, cardiovascular disease and possibly dementia. There is uncertainty about the diagnosis, time course...

  29. Hearing loss prevalence in people who under-present for hearing loss:- What is the prevalence of hearing loss among populations who under-present for possible hearingloss?

    report their difficulties. These include people with learning disabilities, dementia and mild cognitive impairment.Given the importance...

  30. Pneumonia: diagnosis and management (QS110)

    This quality standard covers diagnosing, assessing and treating community-acquired and hospital-acquired pneumonia in babies over 1 month (corrected gestational age), children, young people and adults. It describes high-quality care in priority areas for improvement. It does not cover ventilator associated pneumonia or COVID-19 pneumonia.

  31. Quality standards advisory committee members

    Read biographies of the members of our quality standards advisory committee.

  32. Quality standards advisory committee members

    Read biographies of the members of our quality standards advisory committee.

  33. LQD Spray for treating acute and chronic wounds (MIB202)

    NICE has developed a medtech innovation briefing (MIB) on LQD Spray for treating acute and chronic wounds .

  34. COVID-19 rapid guideline: managing COVID-19 (NG191)

    This guideline covers managing COVID-19 in babies, children, young people and adults in community and hospital settings. It includes recommendations on communication, assessment, therapeutics for COVID-19, non-invasive respiratory support, preventing and managing acute complications, and identifying and managing co-infections.

  35. Decision-making and mental capacity (NG108)

    This guideline covers decision-making in people 16 years and over who may lack capacity now or in the future. It aims to help health and social care practitioners support people to make their own decisions where they have the capacity to do so. It also helps practitioners to keep people who lack capacity at the centre of the decision-making process.

  36. Indicator advisory committee members

    Read biographies for all members of NICE's indicator advisory committee.

  37. Indicator advisory committee members

    Read biographies for all members of NICE's indicator advisory committee.

  38. Suspected neurological conditions: recognition and referral (NG127)

    This guideline covers the initial assessment of symptoms and signs that might indicate a neurological condition. It helps non-specialist healthcare professionals to identify people who should be offered referral for specialist investigation.

  39. Bed frames for adults in acute medical or surgical hospital wards: late-stage assessment (HTG759)

    Late stage assessment (LSA) guidance on bed frames for adults in acute medical or surgical hospital wards.

  40. Dementia: supporting people with dementia and their carers in health and social care (CG42)

    This guidance has been updated and replaced by NICE guideline NG97.

  41. Motor neurone disease (QS126)

    This quality standard covers assessing and managing motor neurone disease, including care, support and planning after diagnosis. It describes high-quality care in priority areas for improvement.

  42. Dementia: independence and wellbeing (QS30)

    This quality standard has been updated and replaced by NICE quality standard 184

  43. Safe staffing for nursing in adult inpatient wards in acute hospitals (SG1)

    This guideline covers organisational and managerial approaches to safe nurse staffing of inpatient wards for people aged 18 and over in acute hospitals. It aims to ensure that patients receive the nursing care they need, regardless of the ward to which they are allocated, the time of the day, or the day of the week.

  44. What training, support or interventions help to reduce caring-related accidents or incidents?

    evidence suggested that START was cost effective for carers of people with dementia and the committee agreed that it was reasonable to...

  45. HIV testing: encouraging uptake (QS157)

    This quality standard covers interventions to improve the uptake of HIV testing among people who may have undiagnosed HIV. It focuses on increasing testing to reduce undiagnosed infection in people at increased risk of exposure. It describes high-quality care in priority areas for improvement.

  46. Technology appraisal committee D members

    Find out more about NICE technology appraisals advisory committee D members

  47. Technology appraisal committee D members

    Find out more about NICE technology appraisals advisory committee D members

  48. Schizophrenia: lurasidone (ESNM48)

    Summary of the evidence on lurasidone (Latuda) for schizophrenia in adults aged 18 and over to inform local NHS planning and decision-making